Malaysia Cardiovascular Devices Market Segmented By Type (Diagnostic & Monitoring Devices, Surgical Devices), By Application (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Source (Import, Domestic), By Region, Competition, Forecast and Opportunities, 2018-2028 2018-2028
Published on: 2024-11-05 | No of Pages : 320 | Industry : Healthcare
Publisher : MIR | Format : PDF&Excel
Malaysia Cardiovascular Devices Market Segmented By Type (Diagnostic & Monitoring Devices, Surgical Devices), By Application (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Source (Import, Domestic), By Region, Competition, Forecast and Opportunities, 2018-2028 2018-2028
It has been reported that
In addition to sedentary lifestyles, unhealthy diets are also contributing to the rising incidence of CVDs in Malaysia. The traditional Malaysian diet is high in fat, sugar, and salt, and lacks enough fruits, vegetables, and whole grains. The consumption of processed foods and sugary drinks has also increased in recent years, contributing to the growing problem of obesity and related health issues. The combination of sedentary lifestyles and unhealthy diets is a major risk factor for CVDs. People who lead sedentary lifestyles are more likely to develop high blood pressure, high cholesterol, and other risk factors for CVDs. Similarly, those who consume a diet high in fat, sugar, and salt are more likely to develop obesity, diabetes, and other health problems that increase the risk of CVDs.
According to the United Nations Population Fund (UNFPA), the elderly population in Malaysia, aged 60 years and above, will increase from 3.2 million in 2020 to 5.3 million by 2030.
Increasing Prevalence of Cardiovascular Diseases in Malaysia
Cardiovascular diseases (CVDs) are one of the leading causes of death in Malaysia, with an estimated 40% of all deaths in the country attributed to CVDs.
According to the National Health and Morbidity Survey (NHMS) in 2019, 21.6% of Malaysians aged 18 years and above had hypertension, and 6.1% had diabetes mellitus.
According to the World Population Prospects report by the United Nations, the proportion of Malaysia's population aged 65 and above is expected to increase from 5.2% in 2020 to 15.2% in 2050.
Furthermore, the urbanization and economic development have also contributed to the increasing prevalence of CVDs in Malaysia. As people move from rural areas to urban centers, they tend to adopt more sedentary lifestyles and unhealthy diets, which increases the risk of developing CVDs. Additionally, economic development has led to increased availability and consumption of processed foods, which are high in salt, sugar, and fat, and contribute to the development of CVDs.
Download Free Sample ReportGovernment's Efforts to Improve Healthcare Infrastructure and Services in Malaysia
The government of Malaysia has made significant efforts in recent years to improve the country's healthcare infrastructure and services.
One of the key initiatives undertaken by the government is the construction of new hospitals and healthcare facilities. The government has invested in building new hospitals in areas where there is a shortage of healthcare facilities. This has helped to improve access to healthcare for people living in rural and remote areas. Additionally, the government has established new healthcare centers and clinics, which have increased the availability of primary healthcare services.
These efforts are aimed at improving access to quality healthcare for all citizens and ensuring that the healthcare system can meet the growing demand for services.
Another important initiative is the implementation of a national health insurance scheme, known as the MySalam scheme.
The government has also invested in medical technology and equipment to improve the quality of healthcare services. This includes the purchase of advanced medical equipment, such as magnetic resonance imaging (MRI) machines, positron emission tomography (PET) scanners, and robotic surgery systems. Additionally, the government has established centers of excellence in various medical specialties, such as cardiology, neurology, and oncology, to ensure that patients receive the highest quality of care.
Another important aspect of the government's efforts to improve healthcare infrastructure and services is the training and education of healthcare professionals. The government has invested in the education and training of healthcare professionals, including doctors, nurses, and allied health professionals. This has helped to improve the quality of healthcare services and ensure that patients receive the best possible care.
Finally, the government has implemented policies to encourage the adoption of technology in healthcare delivery. This includes the development of electronic medical records (EMRs), which enable healthcare professionals to access patient information quickly and easily. The government has also encouraged the use of telemedicine, which allows patients to receive healthcare services remotely, reducing the need for in-person consultations.
Advancements in Technology
The cardiovascular devices market in Malaysia has been growing rapidly in recent years, driven in part by advancements in technology. These advancements have enabled the development of more innovative and effective devices for the prevention, diagnosis, and treatment of cardiovascular diseases (CVDs). Some of the key advancements in technology that are driving the growth of the Malaysia cardiovascular devices market are
The advancements in technology are driving the growth of the Malaysia cardiovascular devices market by improving patient outcomes, reducing recovery time, and offering new treatment options for patients with CVDs. These advancements have also increased the demand for cardiovascular devices, creating new opportunities for manufacturers and distributors in the market.
Market Segmentation
Malaysia cardiovascular devices market can be segmented by type, application, end user,
Market Players
B. Braun Medical Supplies Sdn Bhd, Abbott Medical Malaysia Sdn Bhd, LivaNova Malaysia SDN BHD, Edwards Lifesciences (M) Sdn Bhd, GE Healthcare Sdn Bhd, BIOTRONIK Medical Devices (Malaysia) SDN BHD, and Terumo Malaysia Sdn. Bhd. are some of the leading players operating in the Malaysia cardiovascular devices market.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, Volume in Million Units, and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | Type Application End User Source |
Regional Scope | West and East |
Key Companies Profiled | B. Braun Medical Supplies Sdn Bhd, Abbott Medical Malaysia Sdn Bhd, LivaNova Malaysia SDN BHD, Edwards Lifesciences (M) Sdn Bhd, GE Healthcare Sdn Bhd, BIOTRONIK Medical Devices (Malaysia) SDN BHD, and Terumo Malaysia Sdn. Bhd. |
Customization Scope | 10% free report customization with purchase. Addition or alteration to country, and regional & segment scope. |
Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |